Table 1 Characteristics of women infected with SARS-CoV-2 during pregnancy by pneumonia
Pregnant women | No pneumonia | Pneumonia | p-value* | OR | |
|---|---|---|---|---|---|
N = 105a | N = 72 | N = 32 | |||
Age (years) | 34.1 (28.8–37.1) | 34.3 [28.5;37.2] | 34.0 [31.8;36.4] | 0.778 | 1.01 [0.94;1.08] |
Ethnics | 0.669 | ||||
Caucasian | 63 (60.%) | 44 (61.1%) | 18 (56.2%) | ||
African | 2 (1.9%) | 2 (2.78%) | 0 (0.00%) | ||
Arabic | 1 (1%) | 1 (1.39%) | 0 (0.00%) | ||
LA | 30 (28.6%) | 19 (26.4%) | 11 (34.4%) | ||
GA at diagnosis (w) | 36.9 (33.4–39.2) | 38.2 [35.5;39.8] | 34.3 [28.2;36.4] | < 0.001 | 0.83 [0.75;0.92] |
Time of diagnosis | 0.027 | ||||
Second trimester | 7 (6.7%) | 2 (2.78%) | 5 (15.6%) | Ref. | |
Third trimester | 98 (93.3%) | 70 (97.2%) | 27 (84.4%) | 0.16 [0.02;0.85] | |
Blood group | 0.640 | ||||
O | 46 (43.8%) | 32 (44.4%) | 13 (40.6%) | Ref. | |
A | 42 (40.0%) | 29 (40.3%) | 13 (40.6%) | 1.1 [0.43;2.78] | |
B | 10 (9.5%) | 5 (6.94%) | 5 (15.6%) | 2.46 [0.59;10.3] | |
AB | 5 (4.8%) | 4 (5.56%) | 1 (3.12%) | 0.61 [0.03;4.67] | |
Rh Positive | 91 (86.7%) | 64 (88.9%) | 27 (84.4%) | 0.314 | 0.51 [0.14;1.96] |
Any comorbidity | 36 (34.3%) | 20 (27.8%) | 15 (46.9%) | 0.093 | 2.27 [0.95;5.48] |
Symptomatology | 68 (64.8%) | 35 (48.6%) | 32 (100%) | < 0.001 | |
Pneumonia COVID-19 | 32 (30.8%) | ||||
Treatment | 46 (43.8%) | 14 (19.4%) | 32 (100%) | < 0.001 | |
Need of ICU admission | 5 (4.8%) | 0 (0.00%) | 5 (15.6%) | 0.002 | |
Days at ICU | 10.0 [6.5–18.5] | 10.0 [6.5–18.5] | |||
RT-PCR+ at delivery | 65 (61.9%) | 45 (62.5%) | 19 (59.4%) | 0.933 | 0.88 [0.37;2.10] |
Caesarean section | 38 (36.2%) | 18 (25.0%) | 20 (62.5%) | 0.004 | 4.88 [2.02;12.4] |
GA at delivery (w) | 39.0 [37.4;40.0] | 39.2 [38.4;40.1] | 38.4 [34.1;39.9] | 0.006 | 0.74 [0.62;0.89] |
Preterm birth | 21 (20.6%) | 8 (11.6%) | 13 (40.6%) | 0.002 | 5.08 [1.85;14.9] |